Biomarin Pharmaceutical Balance Sheet (2009-2026) | BMRN

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Balance Sheet	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Assets
Current Assets
Cash & Equivalents (Quarter)	641.53M	617.14M	587.28M	605.44M	619.80M	761.51M	724.53M	580.07M	694.38M	785.41M	755.13M	747.00M	972.15M	675.45M	942.84M	1,048.80M	1,213.82M	1,250.11M	1,311.68M	2,222.43M
Short-term Investments (Quarter)	481.86M	462.33M	426.60M	450.80M	489.94M	512.25M	567.01M	572.02M	476.58M	340.43M	318.68M	299.58M	252.20M	255.00M	194.86M	223.53M	218.31M	227.73M	248.93M
Cash & Current Investments (Quarter)	1,123.40M	1,079.48M	1,013.88M	1,056.24M	1,109.75M	1,273.77M	1,291.54M	1,152.09M	1,170.96M	1,125.85M	1,073.81M	1,046.58M	1,224.35M	930.44M	1,137.71M	1,272.34M	1,432.12M	1,477.84M	1,560.61M	2,222.43M
Receivables - Net (Quarter)	424.42M	374.94M	373.40M	430.15M	466.51M	419.62M	461.32M	597.91M	610.22M	572.50M	633.70M	637.16M	691.23M	777.55M	660.53M	739.18M	855.86M	790.27M	908.21M	903.91M
Receivables - Other (Quarter)
Receivables (Quarter)	424.42M	374.94M	373.40M	430.15M	466.51M	419.62M	461.32M	597.91M	610.22M	572.50M	633.70M	637.16M	691.23M	777.55M	660.53M	739.18M	855.86M	790.27M	908.21M	903.91M
Raw Materials (Quarter)	83.72M	75.33M
Work In Process (Quarter)	373.95M	412.43M
Finished Goods (Quarter)	253.30M	261.64M
Inventory (Quarter)	710.98M	749.41M	776.67M	786.36M	802.32M	839.46M	894.08M	918.92M	975.55M	1,032.16M	1,107.18M	1,137.98M	1,183.62M	1,179.34M	1,232.65M	1,274.85M	1,340.17M	1,382.17M	1,298.88M	1,273.22M
Current Deferred Tax Assets (Quarter)
Prepaid Assets (Quarter)	99.05M	107.75M	110.44M	121.28M	139.03M	149.85M	104.52M	173.18M	193.39M	224.81M	141.39M	163.29M	160.43M	169.26M	201.53M	181.54M	177.18M	204.26M	185.78M	205.50M
Current Assets (Quarter)	2,357.84M	2,311.57M	2,274.39M	2,394.02M	2,517.60M	2,682.70M	2,751.46M	2,842.11M	2,950.12M	2,955.31M	2,956.09M	2,985.01M	3,259.63M	3,056.59M	3,232.43M	3,467.91M	3,805.33M	3,854.54M	3,953.49M	4,605.07M
Non-Current Assets
Buildings (Quarter)
Construction in Progress (Quarter)
Land & Improvements (Quarter)
Property, Plant & Equipment (Net) (Quarter)	1,026.58M	1,024.79M	1,035.46M	1,039.54M	1,049.46M	1,051.82M	1,073.37M	1,068.14M	1,067.28M	1,067.16M	1,066.13M	1,060.42M	1,052.90M	1,045.41M	1,043.04M	1,032.61M	1,030.38M	1,038.19M	952.51M	958.07M
Long-Term Investments (Quarter)	350.24M	466.62M	507.79M	462.83M	412.50M	372.30M	333.83M	340.63M	385.78M	548.00M	611.13M	620.55M	557.08M	561.99M	521.24M	506.72M	508.59M	512.94M	492.24M
Goodwill (Quarter)	196.20M	196.20M	196.20M	196.20M	196.20M	196.20M	196.20M	196.20M	196.20M	196.20M	196.20M	196.20M	196.20M	196.20M	196.20M	196.20M	196.20M	196.20M	196.20M	196.20M
Intangibles (Quarter)	394.30M	388.49M	388.65M	374.25M	369.37M	354.02M	338.57M	325.99M	310.34M	302.48M	294.70M	279.65M	265.53M	260.92M	255.28M	247.35M	239.62M	233.11M	213.84M	204.66M
Goodwill & Intangibles (Quarter)	590.50M	584.69M	584.85M	570.45M	565.57M	550.22M	534.77M	522.19M	506.54M	498.68M	490.90M	475.85M	461.73M	457.12M	451.48M	443.55M	435.82M	429.31M	410.04M	400.86M
Long-Term Deferred Tax (Quarter)	1,431.68M	1,445.11M	1,450.16M	1,446.68M	1,448.91M	1,455.20M	1,505.41M	1,510.57M	1,509.29M	1,523.95M	1,545.81M	1,546.04M	1,545.01M	1,530.78M	1,489.37M	1,460.57M	1,427.02M	1,509.11M	1,508.70M	1,500.60M
Other Non-Current Assets (Quarter)	141.66M	144.71M	152.12M	149.19M	151.80M	151.79M	176.24M	150.06M	144.17M	165.07M	171.54M	184.79M	190.77M	199.31M	251.39M	235.65M	249.19M	270.78M	277.05M	276.42M
Non-Current Assets (Quarter)	3,540.66M	3,665.91M	3,730.39M	3,668.68M	3,628.24M	3,581.34M	3,623.62M	3,591.59M	3,613.05M	3,802.86M	3,885.51M	3,887.66M	3,807.49M	3,794.61M	3,756.51M	3,679.10M	3,651.01M	3,760.32M	3,640.53M	3,985.95M
Assets (Quarter)	5,898.50M	5,977.48M	6,004.77M	6,062.71M	6,145.84M	6,264.04M	6,375.07M	6,433.69M	6,563.17M	6,758.16M	6,841.60M	6,872.67M	7,067.12M	6,851.19M	6,988.94M	7,147.01M	7,456.34M	7,614.87M	7,594.02M	8,591.02M
Liabilities
Current Liabilities
Accounts Payables (Quarter)	411.13M	466.71M	498.26M	426.42M	434.77M	492.72M	572.96M	598.23M	597.23M	669.83M	683.15M	593.54M	572.50M	715.66M	606.99M	628.21M	684.25M	798.44M	759.03M	793.15M
Payables (Quarter)	411.13M	466.71M	498.26M	426.42M	434.77M	492.72M	572.96M	598.23M	597.23M	669.83M	683.15M	593.54M	572.50M	715.66M	606.99M	628.21M	684.25M	798.44M	759.03M	793.15M
Accumulated Expenses (Quarter)
Other Accumulated Expenses (Quarter)
Short term Debt (Quarter)	32.20M	48.19M	48.23M	64.00M	29.95M	28.30M					493.88M	494.36M	494.84M
Current Taxes (Quarter)
Current Deferred Revenue (Quarter)
Total Current Liabilities (Quarter)	443.34M	514.90M	546.50M	490.42M	464.73M	521.02M	588.88M	598.23M	597.23M	1,163.22M	1,177.02M	1,087.90M	1,067.34M	715.66M	606.99M	628.21M	684.25M	798.44M	759.03M	793.15M
Non-Current Liabilities
Convertible Debt (Quarter)	1,077.11M	1,078.09M	1,079.08M	1,080.06M	1,081.05M	1,082.03M	1,083.02M	1,084.01M	1,084.99M	592.59M	1,086.97M	1,087.96M	594.12M	594.63M	595.14M	595.65M	596.16M	596.66M	597.18M
Non-Current Deffered Revenue (Quarter)
Non-Current Deferred Tax Liability (Quarter)
Other Non-Current Liabilities (Quarter)	63.00M	15.20M	15.17M	100.91M		92.47M	100.02M	92.42M	98.12M	105.46M	119.94M	117.35M	119.37M	127.51M	128.82M	129.69M	148.82M	163.06M	150.82M	155.47M
Total Non-Current Liabilities (Quarter)	1,593.92M	1,696.12M	1,723.94M	1,570.48M	1,641.03M	1,603.05M	1,671.90M	1,682.24M	1,682.22M	1,755.81M	1,770.12M	1,681.51M	1,661.45M	1,310.29M	1,202.13M	1,223.86M	1,280.41M	1,395.10M	1,356.21M	2,223.43M
Total Liabilities (Quarter)	1,656.92M	1,711.33M	1,739.10M	1,671.39M	1,641.03M	1,695.53M	1,771.92M	1,774.65M	1,780.35M	1,861.27M	1,890.05M	1,798.86M	1,780.82M	1,437.80M	1,330.95M	1,353.55M	1,429.23M	1,558.16M	1,507.02M	2,378.91M
Shareholder's Equity
Total Debt (Quarter)	32.20M	48.19M	48.23M	64.00M	29.95M	28.30M					493.88M	494.36M	494.84M
Common Equity (Quarter)	4,236.50M	4,261.08M	4,265.67M	4,386.24M	4,499.74M	4,568.51M	4,603.16M	4,659.04M	4,782.83M	4,896.90M	4,951.55M	5,073.82M	5,286.30M	5,413.40M	5,657.99M	5,793.46M	6,027.11M	6,056.71M	6,087.00M	6,212.11M
Shareholder's Equity (Quarter)	4,236.50M	4,261.08M	4,265.67M	4,386.24M	4,499.74M	4,568.51M	4,603.16M	4,659.04M	4,782.83M	4,896.90M	4,951.55M	5,073.82M	5,286.30M	5,413.40M	5,657.99M	5,793.46M	6,027.11M	6,056.71M	6,087.00M	6,212.11M
Liabilities and Shareholders Equity (Quarter)	5,898.50M	5,977.48M	6,004.77M	6,062.71M	6,145.84M	6,264.04M	6,375.07M	6,433.69M	6,563.17M	6,758.16M	6,841.60M	6,872.67M	7,067.12M	6,851.19M	6,988.94M	7,147.01M	7,456.34M	7,614.87M	7,594.02M	8,591.02M
Retained Earnings (Quarter)	-0.94M	10.24M	-930.76M	-804.89M	-777.23M	-788.95M	-3.87M	-738.35M	-682.31M	6.26M	-621.55M	-532.89M	26.80M	-319.64M	-194.69M	19.15M	231.52M	-33.94M	-13.47M	-4.24M
Treasury Shares (Quarter)			0.35M				0.40M				4.70M				0.44M				5.23M

Research Tools

Biomarin Pharmaceutical Balance Sheet (2009-2026) | BMRN

Create an account

Sign In

Reset Password